167 related articles for article (PubMed ID: 28003767)
1. The benefit of using bladder sub-volume equivalent uniform dose constraints in prostate intensity-modulated radiotherapy planning.
Zhu J; Simon A; Haigron P; Lafond C; Acosta O; Shu H; Castelli J; Li B; De Crevoisier R
Onco Targets Ther; 2016; 9():7537-7544. PubMed ID: 28003767
[TBL] [Abstract][Full Text] [Related]
2. Inverse and forward optimization of one- and two-dimensional intensity-modulated radiation therapy-based treatment of concave-shaped planning target volumes: the case of prostate cancer.
Corletto D; Iori M; Paiusco M; Brait L; Broggi S; Ceresoli G; Iotti C; Calandrino R; Fiorino C
Radiother Oncol; 2003 Feb; 66(2):185-95. PubMed ID: 12648791
[TBL] [Abstract][Full Text] [Related]
3. Radiotherapy of prostate cancer with or without intensity modulated beams: a planning comparison.
De Meerleer GO; Vakaet LA; De Gersem WR; De Wagter C; De Naeyer B; De Neve W
Int J Radiat Oncol Biol Phys; 2000 Jun; 47(3):639-48. PubMed ID: 10837946
[TBL] [Abstract][Full Text] [Related]
4. Online image-guided intensity-modulated radiotherapy for prostate cancer: How much improvement can we expect? A theoretical assessment of clinical benefits and potential dose escalation by improving precision and accuracy of radiation delivery.
Ghilezan M; Yan D; Liang J; Jaffray D; Wong J; Martinez A
Int J Radiat Oncol Biol Phys; 2004 Dec; 60(5):1602-10. PubMed ID: 15590192
[TBL] [Abstract][Full Text] [Related]
5. Dosimetric advantages of IMRT simultaneous integrated boost for high-risk prostate cancer.
Li XA; Wang JZ; Jursinic PA; Lawton CA; Wang D
Int J Radiat Oncol Biol Phys; 2005 Mar; 61(4):1251-7. PubMed ID: 15752907
[TBL] [Abstract][Full Text] [Related]
6. A feasibility study of automated inverse treatment planning for cancer of the prostate.
Reinstein LE; Wang XH; Burman CM; Chen Z; Mohan R; Kutcher G; Leibel SA; Fuks Z
Int J Radiat Oncol Biol Phys; 1998 Jan; 40(1):207-14. PubMed ID: 9422578
[TBL] [Abstract][Full Text] [Related]
7. A novel knowledge-based prediction model for estimating an initial equivalent uniform dose in semi-auto-planning for cervical cancer.
Tao C; Liu B; Li C; Zhu J; Yin Y; Lu J
Radiat Oncol; 2022 Aug; 17(1):151. PubMed ID: 36038941
[TBL] [Abstract][Full Text] [Related]
8. A role for biological optimization within the current treatment planning paradigm.
Das S
Med Phys; 2009 Oct; 36(10):4672-82. PubMed ID: 19928099
[TBL] [Abstract][Full Text] [Related]
9. Comparison of biological-based and dose volume-based intensity-modulated radiotherapy plans generated using the same treatment planning system.
Senthilkumar K; Maria Das KJ
J Cancer Res Ther; 2019 Mar; 15(Supplement):S33-S38. PubMed ID: 30900617
[TBL] [Abstract][Full Text] [Related]
10. Benefit of using biologic parameters (EUD and NTCP) in IMRT optimization for treatment of intrahepatic tumors.
Thomas E; Chapet O; Kessler ML; Lawrence TS; Ten Haken RK
Int J Radiat Oncol Biol Phys; 2005 Jun; 62(2):571-8. PubMed ID: 15890602
[TBL] [Abstract][Full Text] [Related]
11. Conformal irradiation of concave-shaped PTVs in the treatment of prostate cancer by simple 1D intensity-modulated beams.
Fiorino C; Broggi S; Corletto D; Cattaneo GM; Calandrino R
Radiother Oncol; 2000 Apr; 55(1):49-58. PubMed ID: 10788688
[TBL] [Abstract][Full Text] [Related]
12. Effect of bladder filling on doses to prostate and organs at risk: a treatment planning study.
Moiseenko V; Liu M; Kristensen S; Gelowitz G; Berthelet E
J Appl Clin Med Phys; 2006 Apr; 8(1):55-68. PubMed ID: 17592448
[TBL] [Abstract][Full Text] [Related]
13. Radiotherapy treatment of early-stage prostate cancer with IMRT and protons: a treatment planning comparison.
Trofimov A; Nguyen PL; Coen JJ; Doppke KP; Schneider RJ; Adams JA; Bortfeld TR; Zietman AL; Delaney TF; Shipley WU
Int J Radiat Oncol Biol Phys; 2007 Oct; 69(2):444-53. PubMed ID: 17513063
[TBL] [Abstract][Full Text] [Related]
14. Intensity-modulated radiation therapy for pancreatic and prostate cancer using pulsed low-dose rate delivery techniques.
Li J; Lang J; Wang P; Kang S; Lin MH; Chen X; Chen F; Guo M; Chen L; Ma CM
Med Dosim; 2014; 39(4):330-6. PubMed ID: 25087084
[TBL] [Abstract][Full Text] [Related]
15. Postoperative intensity modulated radiation therapy in high risk prostate cancer: a dosimetric comparison.
Digesú C; Cilla S; De Gaetano A; Massaccesi M; Macchia G; Ippolito E; Deodato F; Panunzi S; Iapalucci C; Mattiucci GC; D'Angelo E; Padula GD; Valentini V; Cellini N; Piermattei A; Morganti AG
Med Dosim; 2011; 36(3):231-9. PubMed ID: 20541394
[TBL] [Abstract][Full Text] [Related]
16. Simultaneous beam geometry and intensity map optimization in intensity-modulated radiation therapy.
Lee EK; Fox T; Crocker I
Int J Radiat Oncol Biol Phys; 2006 Jan; 64(1):301-20. PubMed ID: 16289912
[TBL] [Abstract][Full Text] [Related]
17. Pelvic nodal dose escalation with prostate hypofractionation using conformal avoidance defined (H-CAD) intensity modulated radiation therapy.
Hong TS; Tomé WA; Jaradat H; Raisbeck BM; Ritter MA
Acta Oncol; 2006; 45(6):717-27. PubMed ID: 16938815
[TBL] [Abstract][Full Text] [Related]
18. A study of the effects of internal organ motion on dose escalation in conformal prostate treatments.
Happersett L; Mageras GS; Zelefsky MJ; Burman CM; Leibel SA; Chui C; Fuks Z; Bull S; Ling CC; Kutcher GJ
Radiother Oncol; 2003 Mar; 66(3):263-70. PubMed ID: 12742265
[TBL] [Abstract][Full Text] [Related]
19. Single course IMRT plan to deliver 45 Gy to seminal vesicles and 81 Gy to prostate in 45 fractions.
Reddy NM; Sood BM; Sampath S; Mazur A; Osian A; Ravi A; Poli J; Nori D
Technol Cancer Res Treat; 2006 Oct; 5(5):503-11. PubMed ID: 16981793
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of the dosimetric impact of non-exclusion of the rectum from the boost PTV in IMRT treatment plans for prostate cancer patients.
Kassim I; Dirkx ML; Heijmen BJ
Radiother Oncol; 2009 Jul; 92(1):62-7. PubMed ID: 19278745
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
